A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer types ...

A new, highly potent class of immunotherapeutics with unique Velcro-like binding properties can kill diverse cancer ...

Immuneering Corporation upgraded to Strong Buy after positive phase 2a data in pancreatic cancer. Click here to find out why ...

The event, organized by the Middlesex County Office of Health Services, aims to raise awareness and funds for pancreatic ...

Truist analysts called the results "encouraging" while pointing out certain unknowns in the data. Immuneering plans to kick ...

A Cornell-led study has cracked a long-standing mystery in cancer biology: how pancreatic ductal adenocarcinoma (PDAC), one ...

The research focuses on pancreatic ductal adenocarcinoma, a particularly aggressive type of cancer. Despite the tumor being ...

Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and ...

Specific combinations of microbes living in our mouths have been associated with one of the deadliest cancers in humans, ...

(OS) observed at 9 months; standard of care benchmark is ~47% -- 53% progression-free survival (PFS) observed at 9 months; ...

A Cornell-led study has revealed how a deadly form of pancreatic cancer enters the bloodstream, solving a long-standing ...

New platform offers vital peer-to-peer support, shared experiences, and practical knowledge for those affected by pancreatic ...